ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding

Clinical trial NCT00616460 · COMPLETED

Trial details

NCT number: NCT00616460
Sponsor: HaEmek Medical Center, Israel
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hematologic Diseases

Start date: 2008-02-01
Primary completion: 2011-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.